Trials / Completed
CompletedNCT02151513
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- University of Utah · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.
Detailed description
Biomarkers of immune function will be measured before and after patients receive an intrathecal pain pump for management of cancer pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intrathecal Pump Placement |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2014-05-30
- Last updated
- 2023-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02151513. Inclusion in this directory is not an endorsement.